AN
Anil Nandlal Singh
About Anil Nandlal Singh
Data last updated:
Anil Nandlal Singh is a Director at Trident Lifecare Private Limited (since 2020), Director at Diatx Biotech Private Limited (since 2019) and Director at Triomaxx Biotech Private Limited (since 2026). The companies operate in Pharma and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹16.04 Cr; the largest is Trident Lifecare Private Limited at ₹13.71 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Trident Lifecare Private Limited U51397MH2020PTC338230 | Director | 25 Feb 2020 | 2020 | ₹13.71 Cr (FY 2025) | Active |
 Diatx Biotech Private Limited U33110MH2019PTC321420 | Director | 19 Feb 2019 | 2019 | ₹2.34 Cr (FY 2024) | Active |
 Triomaxx Biotech Private Limited U21002MH2026PTC473693 | Director | 18 Jul 2026 | 2026 | Active |
Board colleagues of Anil Nandlal Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sunil Nandlal Singh | 08709992 | Trident Lifecare Private Limited | Director |
| Suryakant Banshidhar Shukla | 05355242 | Diatx Biotech Private Limited | Director |
| Dindayal Ramshiromani Gupta | 11836463 | Triomaxx Biotech Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anil Nandlal Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anil Nandlal Singh
Anil Nandlal Singh currently holds 3 directorships: Trident Lifecare Private Limited (Director, since 25 Feb 2020, revenue ₹13.71 Cr (FY 2025)); Diatx Biotech Private Limited (Director, since 19 Feb 2019, revenue ₹2.34 Cr (FY 2024)); Triomaxx Biotech Private Limited (Director, since 18 Jul 2026).
Anil Nandlal Singh was first appointed on 19 Feb 2019 as Director at Diatx Biotech Private Limited. The most recent appointment on record is 18 Jul 2026 at Triomaxx Biotech Private Limited.
The 2 current companies of Anil Nandlal Singh that report revenue have a combined latest revenue of ₹16.04 Cr: Trident Lifecare Private Limited ₹13.71 Cr (FY 2025); Diatx Biotech Private Limited ₹2.34 Cr (FY 2024).
The current boards of Anil Nandlal Singh's companies include Sunil Nandlal Singh (Trident Lifecare Private Limited), Suryakant Banshidhar Shukla (Diatx Biotech Private Limited), Dindayal Ramshiromani Gupta (Triomaxx Biotech Private Limited).